References and Notes
<A NAME="RU31205ST-1A">1a </A>
Hacksell U.
Daves GD.
Prog. Med. Chem.
1985,
22:
1
<A NAME="RU31205ST-1B">1b </A>
Suzuki K.
Matsumoto T. In Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbial Products
Vol. 2:
Lukacs G.
Springer;
Berlin:
1993.
p.353
<A NAME="RU31205ST-1C">1c </A>
Postema MHD.
C-Glycoside Synthesis
CRC: Florida:
1995.
<A NAME="RU31205ST-2A">2a </A>
Séquin U.
Prog. Chem. Org. Nat. Prod.
1986,
50:
58
<A NAME="RU31205ST-2B">2b </A>
Pluramycin A.
Kondo S.
Miyamoto M.
Naganawa H.
Takeuchi T.
Umezawa H.
J. Antibiot.
1977,
30:
1143
<A NAME="RU31205ST-2C">2c </A>
Séquin U.
Ceroni M.
Helv. Chim. Acta
1978,
61:
2241
<A NAME="RU31205ST-2D">2d </A> Kidamycin:
Furukawa M.
Hayakawa I.
Ohta G.
Iitaka Y.
Tetrahedron
1975,
31:
2989
<A NAME="RU31205ST-3">3 </A>
Hansen MR.
Hurley LH.
Acc. Chem. Res.
1996,
29:
249
<A NAME="RU31205ST-4A">4a </A>
Parker KA.
Koh Y.-H.
J. Am. Chem. Soc.
1994,
116:
11149
<A NAME="RU31205ST-4B">4b </A>
Kaelin DE.
Lopez OD.
Martin SF.
J. Am. Chem. Soc.
2001,
123:
6937
<A NAME="RU31205ST-4C">4c </A>
Martin SF.
Pure Appl. Chem.
2003,
5:
63
<A NAME="RU31205ST-5A">5a </A>
Matsumoto T.
Katsuki M.
Suzuki K.
Tetrahedron Lett.
1988,
29:
6935
<A NAME="RU31205ST-5B">5b </A> See also:
Kometani T.
Kondo H.
Fujimori Y.
Synthesis
1988,
1005
<A NAME="RU31205ST-5C">5c </A>
Matsumoto T.
Yamaguchi H.
Tanabe M.
Yasui Y.
Suzuki K.
Tetrahedron Lett.
2000,
41:
8393
<A NAME="RU31205ST-5D">5d </A>
Hosoya T.
Takashiro E.
Matsumoto T.
Suzuki K.
J. Am. Chem. Soc.
1994,
116:
1004
<A NAME="RU31205ST-6A">6a </A>
Ben A.
Yamauchi T.
Matsumoto T.
Suzuki K.
Synlett
2004,
225
<A NAME="RU31205ST-6B">6b </A> For a review on the use of Sc(OTf)3 in organic synthesis, see:
Kobayashi S.
Eur. J. Org. Chem.
1999,
15
<A NAME="RU31205ST-7">7 </A>
Procedure for the Preparation of Mono-
C
-Glycoside 7.
To a stirred mixture of Sc(OTf)3 (67.0 mg, 0.136 mmol), mono-protected resorcinol derivative 6 (1.00 g, 2.76 mmol), powdered Drierite® (1.4 g) in 1,2-dichloroethane (27 mL), was added fucosyl acetate 5 (659 mg, 1.38 mmol) in 1,2-dichloroethane (8 mL) at -30 °C. After the temperature
was gradually raised to 0 °C during 4.5 h, the mixture was poured into sat. aq NaHCO3 solution. After filtration through a Celite® pad, the products were extracted with EtOAc (3×), and the combined organic extracts
were washed with brine, and dried over Na2 SO4 . Removal of the solvents in vacuo and purification by silica gel chromatography (hexane-acetone-CH2 Cl2 = 20:1:1) afforded C -glycoside 7 (1.02 g, 95%); mp 120-121 °C (hexane-EtOAc).
<A NAME="RU31205ST-8">8 </A>
The reaction of compound 8a and fucosyl acetate 5 (2 equiv) under the Sc(OTf)3 -promoted conditions [25 mol% of Sc(OTf)3 , Drierite® , 1,2-dichloroethane, -30 °C to T °C] is shown below. The outcome was not satisfactory,
but was better than those from other attempted conditions. When the reaction was stopped
at 0 °C, the desired bis-C -glycoside 28 was obtained in 48% yield along with the O -glycoside 27 (29%). This shows that the protection of one of the phenolic hydroxyls remarkably
retards both of the O-glycosylation and the migration of the sugar [note: the reaction
of 8e and 5 went to completion at 0 °C]. Further warming of the reaction accelerated the O-glycosidation
and the migration of the sugar, but also caused undesired reactions to give many side
products including 29 as the main constituent, which was most probably formed by the hydride shift from
the C(5) of the sugar to the C(1) (see A ). The yield of 28 did not exceed 68%. Prolongation of the reaction time around 0 °C did not give better
result (Scheme
[4 ]
).
Scheme 4
<A NAME="RU31205ST-9">9 </A>
Molecular sieves (5A) are also usable but the reactions thereof required somewhat
higher temperature and longer reaction period.
<A NAME="RU31205ST-10">10 </A>
Bis-C -glycoside 9 : mp 131-132 °C; [α]D
30 -18.0 (c 1.02, CHCl3 ). 1 H NMR (400 MHz, CDCl3 ): δ = 1.26 (d, 6 H, J = 6.0 Hz, H-6), 2.17 (s, 3 H, ArCH
3
), 3.60-3.61 (m, 4 H, H-2,5), 3.71 (d, 2 H, J = 1.6 Hz, H-4), 3.84 (d, 2 H, J = 10.2 Hz, benzylic), 4.14-4.15 (m, 4 H, H-1,3), 4.46 (d, 2 H, J = 10.2 Hz, benzylic), 4.76 (d, 2 H, J = 12.0 Hz, benzylic), 4.77 (d, 2 H, J = 12.2 Hz, benzylic), 4.82 (d, 2 H, J = 12.0 Hz, benzylic), 5.11 (d, 2 H, J = 12.2 Hz, benzylic), 6.71 (s, 1 H, ArH ), 7.04-7.41 (m, 30 H, Ph CH2 ), 7.95 (s, 2 H, ArOH ). 13 C NMR (75 MHz, CDCl3 ): δ = 8.2, 17.5, 72.7, 74.4, 74.6, 75.3, 76.6, 78.5, 82.3, 83.9, 113.6, 114.3, 127.3,
127.4, 127.48, 127.53, 127.90, 127.95, 128.2, 128.4, 128.7, 137.9, 138.56, 138.64,
154.9. Anal. Calcd for C61 H64 O10 : C, 76.54; H, 6.74. Found: C, 76.24; H, 6.81. ORTEP drawing of 9 is shown below (Figure
[3 ]
).
Figure 3
<A NAME="RU31205ST-11">11 </A>
TBDPS ether, when employed as the protecting group of a phenolic hydroxyl of methyl
2,6-dihydroxybenzoate, did not survive in the reaction. Thus, we opted for the allyl
ether instead.